Search

everythinglearnresearchcommunity

for

Search:↓

Skin diseases like acne and psoriasis are linked to stress, gut health, and inflammation, with new treatments focusing on gut and mind-body approaches.

Certain probiotics can help improve skin conditions like atopic dermatitis, but more research is needed.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Improving education, training, and access to affordable treatments is crucial for better managing inflammatory skin diseases in Latin America.

Mitochondrial dysfunction links metabolic syndrome and inflammatory skin diseases, suggesting targeted therapies and lifestyle changes.

Stem-cell therapy shows promise for skin conditions but needs more research.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

The convention discussed various skin conditions, treatments, and the importance of continuous learning in dermatology nursing.

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

Psoriasis patients have more comorbidities, including autoimmune diseases and other health issues, than those without psoriasis.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

The document discusses how to identify and manage common skin conditions in children.

Hidradenitis suppurativa severely impacts quality of life, especially with severe symptoms and certain comorbidities, and current treatments don't significantly improve it.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Poliosis is common in severe alopecia areata but doesn't significantly affect overall prognosis.

Psychological issues with skin problems worsen patients' lives and treatment.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

Behavior therapy and medications, especially clomipramine, can help reduce hair pulling in people with trichotillomania.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Psoriasis worsens in winter in India due to less sunlight and dry skin, needing personalized treatment.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

Nutrition is important for skin health, and changing diet can help prevent and treat skin diseases.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Stress can worsen skin conditions by affecting hormone levels and immune response.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

The Korean study found that twenty-nail dystrophy mainly affects adults, more often women, and has five distinct types with different clinical progressions.